fashion -WSS

fashion

author：Wikipedia 2025-09-30 18:21:33 - browse：28

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Covid isolation guidance eased by the CDC

WSS

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Medical device lobby: We're tired of waiting on Medicare coverage

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Biotech companies concerned about China biosecurity crackdown

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Kenai launches with $82 million for Parkinson’s stem cell therapy

focus

fashion

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Medical leaders decry Supreme Court decision on affirmative action

Flu vaccine offering decent levels of protection this winter, new data show

Medical records are filled with copy

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

At least 13 dead in Texas as scorching temps continue

What to know about a major upcoming Wegovy heart health study

Alkermes shareholders re

In search for therapies for solid tumors, companies turn to claudin

explore

Kenai launches with $82 million for Parkinson’s stem cell therapy

Obesity now affects over 1 billion people worldwide, study finds

In search for therapies for solid tumors, companies turn to claudin

Why getting cancer drugs just got harder for rural patients

With fresh data, a dynamic duo powers Eli Lilly to new heights

North Korean leader's powerful sister says warplanes repelled US spy plane

hotspot

focus

focus

knowledge